The spectrum of composite autonomic severity score in SCA1, SCA2 and SCA3 patients
Objective: To analyze composite autonomic severity score in patients of spinocerebellar ataxia types 1, 2 and 3. Background: Spinocerebellar ataxia (SCA) is a progressive neurodegenerative…Burden of autonomic neuropathy in Parkinson’s disease patients treated with advanced therapies
Objective: To analyze the prevalence and the functional burden of autonomic neuropathy (AN) in advanced Parkinson’s disease (PD) patients who underwent subthalamic deep brain stimulation…Striatal dopamine transporter abnormalities in pure autonomic failure and speculation about the relationship with Lewy bodies
Objective: To reveal dopamine transporter (DAT) abnormalities in pure autonomic failure (PAF) and speculate about the relationship with the Lewy body progression pathway. Background:…Where Are The Main Lesions That Cause Orthostatic Hypotension In Parkinson’s Disease ?
Objective: To clarify the responsible lesion of orthostatic hypotension (OH) in Parkinson’s disease (PD) by measuring the catecholamine level and using a cardiac MIBG scintigraphy.…Effect of Droxidopa Treatment on Fear of Falling in Patients With Neurogenic Orthostatic Hypotension: Clinical Trial and “Real World” Results
Objective: To assess the impact of droxidopa on fear of falling in patients with symptomatic neurogenic orthostatic hypotension (nOH) in 2 studies. Background: nOH results…Autonomic Dysfunction in Early Parkinson’s Disease: Cross-Sectional Study in Hoehn and Yahr Stage 1
Objective: To define frequency, severity and predictors of dysautonomia in patients with Parkinson's disease(PD) at the stage of hemiparkinsonism with disease duration less than 2…Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease
Objective: To evaluate the association between melatonin secretion rhythm and nocturnal polyuria, and the pathophysiology of nocturnal polyuria in PD. Background: Patients with PD have…Clean intermittent catheterization in Parkinson’s disease: a case report
Objective: Describe the interdisciplinary actions that resulted in the therapeutic indication of a clean intermittent bladder catheterization in a patient with detrusor areflexia related to…Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?
Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease
Objective: To determine the feasibility and value of remote blood pressure (BP) monitoring during a clinical trial of isradipine (a dihydropyridine calcium channel antagonist) in…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- 22
- Next Page »